Trial
NCT03552796
sEphB4-HSA in Treating Participants With BCG-Unresponsive or Refractory Bladder Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Southern California
Collaborators
National Cancer Institute (NCI)
Condition
Recurrent Bladder Carcinoma
Intervention
Pharmacokinetic Study
Why stopped
Budget issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-26